ExploreWatchlistsPricing
  1. JP-listed companies
  2. TSUMURA & CO.
  3. Financials
  4. Total current assets

TSUMURA & CO. (4540)

Market cap
¥290.1B
P/E ratio
11.8x
Tsumura manufactures prescription and over-the-counter medicines, specializing in herbal extract powders and raw medicinal herbs across Japan, China, Laos, and the US.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal current assets (Million JPY)YoY (%)
Mar 31, 2025295,709+5.13%
Mar 31, 2024281,292+4.83%
Mar 31, 2023268,320+16.96%
Mar 31, 2022229,420+12.31%
Mar 31, 2021204,273+5.14%
Mar 31, 2020194,288+2.24%
Mar 31, 2019190,027-1.23%
Mar 31, 2018192,401+42.86%
Mar 31, 2017134,679+0.76%
Mar 31, 2016133,668+4.03%
Mar 31, 2015128,484

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat